XML 233 R54.htm IDEA: XBRL DOCUMENT
v3.26.1

Segment Information (Tables) | 12 Months Ended
--- | ---
May 31, 2025
DiamiR Biosciences Corp. [Member] |
Segment Information [Line Items] |
Schedule of Segment Revenue and Expenses | Segment revenue and expenses are as follows in the years ended May 31, 2025 and 2024.
|  | 2025 |  | 2024
Revenue |  | $ | 631,729 |  |  | $ | 1,319,531 |
Research and development |  |  |  |  |  |  |  |
Salaries and benefits |  |  | 449,344 |  |  |  | 692,875 |
Consultants and contractors |  |  | 176,935 |  |  |  | 278,837 |
Stock based compensation |  |  | 24,312 |  |  |  | 182,912 |
Other R&D |  |  | — |  |  |  | 2,236 |
Total research and development |  |  | 650,591 |  |  |  | 1,156,860 |
General and administrative |  |  |  |  |  |  |  |
Salaries and benefits |  |  | 105,761 |  |  |  | 117,883 |
Consultants and contractors |  |  | 213,509 |  |  |  | 292,234 |
Stock based compensation |  |  | — |  |  |  | 11,934 |
Patents |  |  | 44,363 |  |  |  | 30,167 |
Depreciation |  |  | 20,828 |  |  |  | 20,052 |
Offering costs |  |  | 150,526 |  |  |  | — |
Rent and facilities |  |  | 53,483 |  |  |  | 55,600 |
Other |  |  | 35,918 |  |  |  | 86,204 |
Total general and administrative |  |  | 624,388 |  |  |  | 614,074 |
Interest expense |  |  | 82,046 |  |  |  | 48,599 |
Income taxes |  |  | 17,939 |  |  |  | 114,403 |
Net loss |  | $ | (743,235 | ) |  | $ | (614,405 | )

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SegmentReportingInformationLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=apm_DiamiRBiosciencesCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |